Long-term levodopa therapy for torsion dystonia

Area of Science:

• Neurology
• Pharmacology

Background:

• Familial torsion dystonia is a rare, inherited movement disorder.
• Levodopa is a primary treatment for dopaminergic deficits, but its efficacy and side effect profile in dystonia require careful management.

Observation:

• A 34-year-old woman with familial torsion dystonia was treated with levodopa over four years.
• Severe adverse effects, including gastrointestinal issues, dyskinesias, cramps, and anxiety, were noted during the initial ten months at maximal dosage.
• A subsequent dose reduction to 1,500 mg daily was implemented.

Findings:

• The reduced levodopa dosage provided excellent relief of hypokinesia and rigidity.
• Minimal adverse effects were observed after dose reduction.
• Mild akinesia paradoxica, which developed after 2.5 years, was abolished with the lower dosage.

Implications:

• Optimizing levodopa dosage may be crucial for managing familial torsion dystonia effectively.
• Long-term treatment strategies should consider dose titration to balance therapeutic benefits and minimize side effects.
• This case highlights the potential for dose adjustment to overcome treatment-limiting adverse events in movement disorders.